GLP-1 weight-loss drug, whose full name is Glucagon-like peptide-1 receptor agonist. Initially, GLP-1 was a hormone secreted by the gastrointestinal tract mainly used for treating diabetes, but it has also been used to suppress appetite and control weight.
Wall Street in the Haze of the Tech Selloff as the AI Promise Lingers - Earnings Scorecard
RSV Vaccine Market to Decline 64% on CDC Decision: Report
Viking Therapeutics's Options: A Look at What the Big Money Is Thinking
Novo Nordisk Unusual Options Activity For July 26
Catalyst Watch: Tech Blitz With Apple, Amazon, Microsoft, and Meta on Tap for Earnings
FDA Issues Warning on Compounded Versions of Novo Nordisk's Semaglutide